A new DNA test aims to make cervical cancer screening more accessible in low-income countries. The test is designed to detect the human papillomavirus (HPV), which is responsible for the majority of cervical cancer cases. Current screening methods for cervical cancer often involve a Pap smear, which requires a trained medical professional and laboratory analysis. The new DNA test is less invasive and can be administered by non-medical professionals. The test has been developed by a team of researchers at the University of Cambridge and has been successfully tested in a pilot program in Botswana. The hope is that the test will help to reduce the number of cervical cancer deaths in low-income countries where access to traditional screening methods is limited.